Optimal management of a patient with recurrent nasopharyngeal carcinoma

被引:0
作者
Francesco Perri [1 ]
Italo Dell’Oca [2 ]
Paolo Muto [3 ]
Concetta Schiavone [3 ]
Corrado Aversa [4 ]
Franco Fulciniti [5 ]
Raffaele Solla [6 ]
Giuseppina Della Vittoria Scarpati [7 ]
Carlo Buonerba [8 ]
Giuseppe Di Lorenzo [8 ]
Francesco Caponigro [1 ]
机构
[1] Head and Neck Medical Oncology Unit,National Tumor Institute of Naples,80131 Naples,Italy
[2] Radiotherapy Unit,S. Raffaele Hospital of Milan,20100 Milan,Italy
[3] Radiotherapy Unit,National tumor Institute of Naples,80131 Naples,Italy
[4] Otolaryngology Unit,National Tumor Institute of Naples,80131 Naples,Italy
[5] Pathology Unit,National Tumor Institute of Naples,80131 Naples,Italy
[6] Institute of Biostructures and Bioimage,National Council of Research (CNR) of Naples,80131 Naples,Italy
[7] Oncology and Molecular Biology Research Unit,University of Salerno,84090 Salerno,Italy
[8] Medical Oncology,University Federico II of Naples,80131 Naples,Italy
关键词
Cetuximab; Nasopharyngeal carcinoma; Reirradiation; Surgery of metastases; Undifferentiated;
D O I
暂无
中图分类号
R739.63 [咽肿瘤];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed, non-metastatic disease, management of recurrent disease is challenging, with a survival expectancy of approximately 6 mo with the use of chemotherapy as the sole salvage treatment. We report a case of recurrent nasopharyngeal carcinoma treated with a combination of chemotherapy, radiotherapy and surgery in the context of a multidisciplinary approach. A durable complete response was achieved.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 10 条
  • [1] Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. Boussen H,Cvitkovic E,Wendling J L,Azli N,Bachouchi M,Mahjoubi R,Kalifa C,Wibault P,Schwaab G,Armand J P. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 1991
  • [2] Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ma J,Mai HQ,Hong MH,et al. Journal of Clinical Oncology . 2001
  • [3] Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies. Perri Francesco,Bosso Davide,Buonerba Carlo,Lorenzo Giuseppe Di,Scarpati Giuseppina Della Vittoria. World journal of clinical oncology . 2011
  • [4] Integrated therapeutic approaches in head and neck cancer:the importance of multidisciplinary team management. Perri F,Muto P,Aversa C,Daponte A,Della Vittoria G,Pepe S,Caponigro F. Anticancer Agents Med Chem . 2013
  • [5] Induction docetaxel-cisplatin followed by extended-field radiotherapy in patients with cervical metastases from unknown primary carcinoma. Perri F,lonna F,Muto P,et al. Anticancer Research . 2013
  • [6] How successful is high-dose (≥60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo, PML
    Kwan, WH
    Chan, ATC
    Lee, WY
    King, WWK
    Mok, CO
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04): : 897 - 913
  • [7] Recurrent nasopharyngeal carcinoma: current management approaches. Smee Robert I,Meagher Nicola S,Broadley Kathryn,Ho Timothy,Williams Janet R,Bridger G Patrick. American journal of clinical oncology . 2009
  • [8] Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Roeder Falk,Zwicker Felix,Saleh-Ebrahimi Ladan,Timke Carmen,Thieke Christian,Bischof Marc,Debus Juergen,Huber Peter. Radiation Oncology . 2011
  • [9] Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma. Anthony T.C. Chan,Mow-Ming Hsu,Boon C. Goh,Edwin P. Hui,Tsang-Wu Liu,Michael J. Millward,Ruey-Long Hong,Jacqueline Whang-Peng,Brigette B.Y. Ma,Ka F. To,Matthias Mueser,Nadia Amellal,Xiao Lin,Alex Y. Cha. Japanese Journal of Clinical Oncology . 2005
  • [10] Treatment approaches to nasopharyngeal carcinoma: a review. Caponigro Francesco,Longo Francesco,Ionna Franco,Perri Francesco. Anti Cancer Drugs . 2010